21:36 IST
NSE
Acquisition
RPG Life Sciences Acquisition
RPG Life Sciences completed its acquisition of the entire stake in Actis Generics Private Limited, making it a subsidiary of the company.
RPG Life Sciences Ltd
- Share price
- ₹3,050.60
- Market cap
- ₹5,045 Cr
- Revenue (annual)
- ₹707.5 Cr
- Net profit (annual)
- ₹115.2 Cr
- P/E (TTM)
- 42.2×Sector 50.4×
- Promoter holding
- 72.95%+0.00% QoQ
- FII holding
- 0.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 4Earnings Call 4Financial Results 2Acquisition 2Price Movement Clarification 1
Time
2 announcements with these filters
22:23 IST
NSE
Acquisition
RPG Life Sciences Acquisition Worth ₹135 Cr
RPG Life Sciences' subsidiary, RPG Active Pharma, will acquire the API business of Raghava Life Sciences for up to ₹135 Crore, expanding its manufacturing capabilities.
- Value
- ₹135.0 Cr
- manufacturing capacity
- 300.0 KL